NCT05023655 2026-03-17
Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation
Prisma Health-Upstate
Phase 2 Terminated
Prisma Health-Upstate
Zhejiang University
Nuvation Bio Inc.
BioNTech SE
Boundless Bio, Inc.
Innovent Biologics (Suzhou) Co. Ltd.